Growth Metrics

Bioregenx (BRGX) Shares Issued (2023)

Bioregenx's quarterly Shares Issued came in at $527088.0 in Q4 2023, up 733.88% quarter-over-quarter from $63209.0 in Q3 2023.

Bioregenx has reported Shares Issued for 1 years, with the latest figure at $527088.0 in Q4 2023.

  • For the quarter ending Q4 2023, Shares Issued changed N/A year-over-year to $527088.0; the trailing twelve-month figure through Sep 2024 stood at $527088.0 (changed N/A YoY), and the FY2023 full-year result was $1.3 million, changed N/A from the prior year.
  • Shares Issued for Q4 2023 stood at $527088.0, up from $63209.0 in the prior quarter.
  • The five-year high for Shares Issued was $527088.0 in Q4 2023, with the low at $63209.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 13.87 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 12.09 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 418,000.00
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 410,000.00
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -3.13 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 2.41 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 273,000.00
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 774,000.00
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 7.76 Mn
10 Bioregenx - - 348,288.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 527,088.00
Dec 31, 2023 527,088.00
Sep 30, 2023 63,209.00
Sep 30, 2023 63,209.00
Jun 30, 2023 414,105.00
Jun 30, 2023 414,105.00
Mar 31, 2023 337,739.00
Mar 31, 2023 337,739.00